Reducing the effective dosage of flutamide on prostate cancer cell lines through combination with selenium nanoparticles: An in-vitro study
It is suggested that simultaneous administration of SeNPs and flutamide could potentially reduce the effective dosage of flutamide and decrease its adverse effects.
Authors
- Akram Mirzaei (ORCID: https://orcid.org/0000-0003-2219-999X)
- Amin Shiralizadeh Dezfuli (ORCID: https://orcid.org/0000-0001-8628-3010)
- Fatemeh Khatami (ORCID: https://orcid.org/0000-0002-6311-1336)
- Iman Menbari Oskouie (ORCID: https://orcid.org/0000-0002-5511-1512)
- Ramin Heshmat (ORCID: https://orcid.org/0000-0002-8134-7940)
- Seyed Mohammad Kazem Aghamir (ORCID: https://orcid.org/0000-0003-1611-0362)
- Rahil Mashhadi (ORCID: https://orcid.org/0000-0003-1788-5282)
- Helia Azodian Ghajar
- Seyedeh Negin Hashemi Dougaheh
Institutions
- University of Tehran (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1371/journal.pone.0318483
- Primary Topic
- Selenium in Biological Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00